首页 >
法规速递
-
Page: Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline-2025/12/18
2025-12-19查看详情 > -
2026年2月4日中药品种保护受理公示-2026/2/4
2026-02-05查看详情 > -
Medical Devices with Indications Associated with Weight Loss - Premarket Considerations-2026/3/13
2026-03-13查看详情 > -
Page: Core summary of product characteristics for human normal immunoglobulin for subcutaneous and intramuscular use - Scientific guideline-2026/4/9
2026-04-10查看详情 > -
Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application-2026/5/29
2026-05-29查看详情 > -
Regulatory and procedural guideline: EudraVigilance registration documents (updated)-2023/01/04
2023-01-04查看详情 > -
关于《腺相关病毒载体类体内基因治疗产品临床试验申请药学研究与评价技术指导原则(征求意见稿)》征求意见的通知-2023/7/25
2023-07-28查看详情 > -
国家药监局关于发布仿制药参比制剂目录(第七十六批)的通告(2024年第8号)-2024/2/4
2024-03-11查看详情 > -
Document: Paclitaxel (nanoparticle albumin-bound) powder for suspension for infusion, 5mg/ml-2025/1/31
2025-02-05查看详情 > -
Document: European Shortages Monitoring Platform (ESMP) data access policy-2025/3/10
2025-03-11查看详情 >